- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
VB Spine to Acquire Augmedics' Spine Platform
Transaction will expand VB Spine's enhanced visualization portfolio with augmented reality navigation technology.
Published on Feb. 17, 2026
Got story updates? Submit your updates here. ›
VB Spine LLC, the largest privately held spine company, has announced it will acquire exclusive rights to the xvision Spine System from Augmedics. The xvision is the first FDA-cleared augmented reality navigation platform for spine surgery, allowing surgeons to visualize a patient's anatomy in real-time during procedures. This acquisition will expand VB Spine's enhanced visualization portfolio and position the company as a leader in AR-enabled spine solutions.
Why it matters
The addition of Augmedics' xvision technology will strengthen VB Spine's ability to provide advanced visualization tools for spine surgeons, improving surgical precision and efficiency while reducing radiation exposure. As augmented reality continues to transform medical procedures, this deal solidifies VB Spine's position at the forefront of innovative spine care solutions.
The details
Under the definitive agreement, VB Spine will acquire exclusive rights to the xvision Spine System, which combines the benefits of navigation with the ease and utility of open spine surgery. The xvision platform allows surgeons to visualize a patient's anatomy as if they have 'x-ray vision' during procedures, providing accurate and precise guidance. This transaction builds on VB Spine's recent acquisition of the SpineHawk intraoperative visualization platform, further expanding the company's enhanced visualization technology portfolio.
- The transaction is expected to close in the coming weeks, subject to approval and customary closing conditions.
The players
VB Spine LLC
The largest privately held spine company and among the largest family-owned medical technology companies in the world, with a comprehensive portfolio and global distribution network.
Augmedics
A company pioneering cutting-edge augmented reality technologies to improve surgical outcomes, and the developer of the FDA-cleared xvision Spine System.
Marc Viscogliosi
Co-CEO of VB Spine.
Paul Ziegler
President and CEO of Augmedics.
What they’re saying
“We have long admired the xvision technology and potential of the platform. We believe with our implant integration and scale, we have the ability to harness the true potential of AR navigation. Combined with the SpineHawk platform, this will expand our existing spine solutions and supports our long-term roadmap to redefine spine care with differentiated technologies.”
— Marc Viscogliosi, Co-CEO of VB Spine (Business Wire)
“We are proud of the clinical impact xvision has made in spine surgery and VB Spine's commitment to our world-class portfolio. This agreement will strengthen our competitive advantage as an augmented reality innovation engine as we turn our focus to expanding our reach into adjacent surgical indications.”
— Paul Ziegler, President and CEO of Augmedics (Business Wire)
What’s next
Subject to approval and closing, VB Spine and Augmedics intend to work together to support an orderly transition for customers.
The takeaway
This acquisition positions VB Spine as a leader in augmented reality-enabled spine solutions, allowing the company to leverage Augmedics' pioneering xvision technology to provide advanced visualization tools that improve surgical precision and efficiency for spine surgeons.
